Literature DB >> 3488334

Autoimmunity in chronic lymphocytic leukaemia.

T J Hamblin, D G Oscier, B J Young.   

Abstract

The prevalence of autoantibodies in B cell chronic lymphocytic leukaemia (B-CLL) was investigated. A lower prevalence of autoimmune haemolytic anaemia than that found in other series was found: large numbers of non-progressive stage A disease cases were included, in which the prevalence of autoimmune haemolytic anaemia is low. Non-haematological autoantibodies were no commoner than in age matched controls. Whatever explanation is offered for autoimmune phenomena in B-CLL it must take account of the fact that those phenomena are virtually confined to autoantibodies against the formed elements of the blood.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488334      PMCID: PMC500029          DOI: 10.1136/jcp.39.7.713

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Autoimmune thrombocytopenic purpura ("ITP" type) with chronic lymphocytic leukemia.

Authors:  S EBBE; B WITTELS; W DAMESHEK
Journal:  Blood       Date:  1962-01       Impact factor: 22.113

2.  Pernicious anaemia and lymphoproliferative disease.

Authors:  A C Parker; M Bennett
Journal:  Scand J Haematol       Date:  1976-11

3.  Pure red blood cell aplasia and chronic lymphocytic leukemia.

Authors:  M D Abeloff; L Waterbury
Journal:  Arch Intern Med       Date:  1974-10

4.  Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time.

Authors:  M M Hansen
Journal:  Scand J Haematol Suppl       Date:  1973

5.  Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia.

Authors:  D Catovsky; F Lauria; E Matutes; R Foa; V Mantovani; S Tura; D A Galton
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

6.  Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation.

Authors:  N E Kay
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

7.  Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL.

Authors: 
Journal:  Br J Haematol       Date:  1981-07       Impact factor: 6.998

8.  X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.

Authors:  F B Lewis; R S Schwartz; W Dameshek
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

9.  Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease.

Authors:  K F Mangan; L D'Alessandro
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

Review 10.  The chronic leukemias: a review of disease manifestations and the aims of therapy.

Authors:  D E Bergsagel
Journal:  Can Med Assoc J       Date:  1967-06-24       Impact factor: 8.262

View more
  31 in total

1.  Systemic sclerosis and chronic lymphocytic leukaemia.

Authors:  Y Sidi; R Fadilah; J Pinkhas; M Prokocimer
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 2.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 3.  A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Authors:  Mazie Tsang; Sameer A Parikh
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

Review 4.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  Chronic lymphocytic leukaemia at a county hospital in southern Sweden.

Authors:  V Hjalmar; M Carlsson; E Kimby
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

6.  Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Authors:  Paul J Hampel; Melissa C Larson; Brian Kabat; Timothy G Call; Wei Ding; Saad S Kenderian; Deborah Bowen; Justin Boysen; Susan M Schwager; Jose F Leis; Asher A Chanan-Khan; Eli Muchtar; Curtis A Hanson; Susan L Slager; Neil E Kay; Kari G Chaffee; Tait D Shanafelt; Sameer A Parikh
Journal:  Br J Haematol       Date:  2018-08-16       Impact factor: 6.998

Review 7.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

Review 8.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

9.  Anti-globulin test positivity indicates advanced disease in Indian CLL patients.

Authors:  Richa Gupta; Neha Garg; Abha Singh
Journal:  Am J Blood Res       Date:  2021-04-15

10.  Treatment of Hypersplenism by Partial Splenic Embolization Through Gastric Collaterals.

Authors:  Souheil Saddekni; Amr Soliman Moustafa; Hany A Tahoon; Mostafa Setita; Ahmed Kamel Abdel-Aal
Journal:  J Radiol Case Rep       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.